Johannes B Reitsma

Statistics and Probability · 2003–2024

A researcher in the Science corpus: 29 papers; trusts 55 researchers and is trusted by 19 researchers here, as inferred from the citation graph.

Subfields

Whom Johannes B Reitsma trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Karel G. M. Moons
  2. Douglas G. Altman
  3. Patrick Royston
  4. Patrick M. M. Bossuyt
  5. Y. Vergouwe
  6. David Moher
  7. Ewout W. Steyerberg
  8. Gary S. Collins
  9. J. Deeks
  10. for the Statistics Subcommittee of the NCI—EORTC Worki Diagnostics

Who trusts Johannes B Reitsma overall

  1. R. Riley
  2. Gary S. Collins
  3. R. Harbord
  4. Karel G. M. Moons
  5. Douglas G. Altman
  6. S. Gilbody
  7. Patrick M. M. Bossuyt
  8. David Moher
  9. A. Rutjes
  10. J. Deeks

Papers from Johannes B Reitsma's perspective

Ordered by how strongly the researchers Johannes B Reitsma trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies (British medical journal)
  2. Regression Modeling Strategies (Technometrics)
  3. Sources of Variation and Bias in Studies of Diagnostic Accuracy (Annals of Internal Medicine)
  4. Updating methods improved the performance of a clinical prediction model in new patients. (Journal of Clinical Epidemiology)
  5. Multiple imputation using chained equations: Issues and guidance for practice (Statistics in Medicine)
  6. The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration (Annals of Internal Medicine)
  7. Evaluation of the Quality of Prognosis Studies in Systematic Reviews (Annals of Internal Medicine)
  8. Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers (Statistics in Medicine)
  9. Risk prediction models: II. External validation, model updating, and impact assessment (Heart)
  10. Prognosis Research Strategy (PROGRESS) 2: Prognostic Factor Research (PLoS Medicine)

Their papers